Mesenchymal stem/stromal cells (MSCs) are an essential element of most modern tissue engineering and regenerative medicine approaches due to their multipotency and immunoregulatory functions. Despite the prospective value of MSCs for the clinics, the stem cells community is questioning their developmental origin, in vivo localization, identification, and regenerative potential after several years of far-reaching research in the field. Although several major progresses have been made in mimicking the complexity of the MSC niche in vitro, there is need for comprehensive studies of fundamental mechanisms triggered by microenvironmental cues before moving to regenerative medicine cell therapy applications. The present comprehensive review extensively discusses the microenvironmental cues that influence MSC phenotype and function in health and disease -including cellular, chemical and physical interactions. The most recent and relevant illustrative examples of novel bioengineering approaches to mimic biological, chemical, and mechanical microenvironmental signals present in the native MSC niche are summarized, with special emphasis on the forefront techniques to achieve bio-chemical complexity and dynamic cultures. In particular, the skeletal MSC niche and applications focusing on the bone regenerative potential of MSC are addressed. The aim of the review was to recognize the limitations of the current MSC niche in vitro models and to identify potential opportunities to fill the bridge between fundamental science and clinical application of MSCs.
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Introduction
Friedenstein and co-workers originally identified a rare sub-population of cells in the BM with the potential to proliferate in plastic-adherent colonies with a fibroblastic appearance, first designated as CFU-Fs (Friedenstein et al., 1974) . Later in vivo experiments have revealed the potential of BM-isolated adherent cells to generate de novo the BM stroma and its environment upon serial transplantation to heterotopic anatomical sites (Caplan, 1991; Owen, 1988) , leading to the current concept of BM-derived MSCs. Although the BM is the most widely recognized source of MSCs, further research has suggested the presence of MSC-like cells in other tissues, including adipose tissue (Zuk et al., 2002) , peripheral blood (Tondreau et al., 2005) , dental pulp (Gronthos et al., 2000) , pancreatic islets (Carlotti et al., 2010) , synovial membrane (Hermida-Gómez et al., 2011) , periodontal ligament (Seo et al., 2004) , anterior cruciate ligament (Prager et al., 2018) , endometrium (Schwab et al., 2008) , bursa subacromialis (Steinert et al., 2015) , placenta (Fukuchi et al., 2004) , umbilical cord (Baksh et al., 2007) , and umbilical cord blood (Sarugaser et al., 2005) . It has been further proposed that MSCs may be present in any vascularized tissue at perivascular sites (Crisan et al., 2008) .
Due to their multipotency and wide dispersion in the body, MSCs are an essential element of most modern tissue engineering and regenerative medicine approaches. There are extensive reviews on the biology of the MSCs, elucidating their nature and unique properties (Bronckaers et al., 2014; Méndez-Ferrer et al., 2010; Phinney and Prockop, 2007; Prockop and Oh, 2012) . In the present review, the different microenvironmental cues influencing the MSC phenotype and function either in health and disease -including cellular, chemical, and physical interactions -are discussed. In addition, the most recent in vitro culture strategies addressing the complexity of the in vivo MSC environment are summarized.
The MSC identity relies on their localization
The characterization of MSCs either ex vivo or in vivo remains difficult since there is neither a distinct definition nor a robust assay to identify MSCs in a mixed population of cells. However, the International Society of Cellular Therapy has established three main criteria that should be fulfilled by genuine MSCs in vitro. These cells should (1) exhibit plastic adherence; (2) express a set of surface markers -i.e., CD73, CD90, CD105, and lack the expression of CD45, CD34, CD14 or CD11b, CD79α or CD19, and HLA-DR; (3) have the ability to differentiate in vitro into mesenchymal lineages, namely adipocyte, chondrocyte, and osteoblast (Dominici et al., 2006) . These criteria are applied for the in vitro characterization and validation of putative MSCs isolated from different tissue sources; however, differences exist in MSCs isolated from various tissue origins for what concerns the clonogenecity level, proliferation rate, differentiation potential, cell surface marker expression, and, most importantly, their regenerative potential in vivo (Bianco et al., 2008; Hass et al., 2011; Raicevic et al., 2011) . In fact, only cells isolated from the BM reestablish the marrow stroma upon serial transplantation in mice (Méndez-Ferrer et al., 2010; Sacchetti et al., 2007) . CD146 + pericytes, firstly isolated from the BM (Bianco et al., 2008) and later from multiple vascularized human organs (Crisan et al., 2008) , exhibit long-term proliferation and trilineage differentiation potential in in vitro cultures. However, pericytes, identified by the expression of the transcription factor Tbx18, maintain their identity during aging and diverse pathological in vivo settings and do not contribute to tissue regeneration (Guimarães-Camboa et al., 2017) , suggesting that the plasticity of these cells observed in vitro can be in fact the result of artificial cell manipulations. Regardless of the controversy, these findings provide evidence that MSCs should not be classified as a uniform population of theoretically multipotent cells, but rather a super-family of tissuespecific committed progenitors, possibly even with a distinct developmental origin, as proposed by Robey (2017) and Sacchetti et al. (2016) . Noteworthy, isolated MSCs seem to reflect an organ-specific potency and a mechanical memory from past physical
The dynamics of the MSC niche
There is abundant evidence suggesting that the MSC ability to maintain themselves or to give rise to differentiated progeny is strictly governed by complex interactions within their close environment -first proposed for HSCs as stem cell niche (Schofield, 1978) . The concept of a stem cell niche has later been established as an interactive structural unit, organized to facilitate cell-fate decisions in a proper spatiotemporal manner, comprising the structural and functional components of the ECM, the cellular signaling with stem adjacent cells and other environmental cues, such as gradients of hypoxia ( Fig. 1) (Li and Xie, 2005; Scadden, 2006) . In vivo remodeling of the stem cell niche occurs constantly during development, e.g., during skeletal development and epithelial branching morphogenesis (Rozario and DeSimone, 2010) or in adults during wound healing (Schultz and Wysocki, 2009) , where both inflammatory, angiogenic, and morphogenetic factors are present, culminating in an adjustment of the mechanochemistry and cellular composition of the tissue.
Age and diseases
The dynamics of the BM niche vary strongly with age and disorder phenotypes. During aging, a quiescence-to-senescence transition occurs in niche-residing MSCs, which strongly impairs the interactive signaling network of all niche-residing cells and ultimately the complete regenerative activity (Herrmann et al., 2019) . This phenomenon is driven either by the age-associated BM fat tissue expansion (Ambrosi et al., 2017) and/or by the inherent modulation of number and type of vessels in bone and BM (Watson and Adams, 2017; Zimmermann et al., 2011) . The signature and proliferation capacity of MSCs is also compromised in ECM-related disorders, such as tissue fibrosis -where an excessive deposition of ECM is observed (Usunier et al., 2014) -or osteoarthritis (Maldonado and Nam, 2013) -which is linked to a resilient ECM degradation mediated primarily by MMPs and to an over-activation of osteoclast activity (Maldonado and Nam, 2013) . Disruption of such control mechanisms generates aberrant ECM, both structurally and mechanically altered, leading to abnormal behaviors of cells residing in the niche and, ultimately, to enormous repercussions on the overall tissue homeostasis and functionality (Bonnans et al., 2014; Cox and Erler, 2011) .
BM niches can also be targeted by metastasizing cancer cells (discussed in more detail below), where a malignant vicious cycle between niche and tumor cells is created, adapting the ECM dynamics to each step of tumor progression (Herrmann et al., 2019; Lu et al., 2012) .
Cellular interactions
MSCs gather in niches in distinct location within the BM -namely endosteal (Nakamura et al., 2010) , stromal (Herrmann et al., 2019; Pereira et al., 1998) , and perivascular (Winkler et al., 2010) . The phenotypical similarities of MSCs within their respective niches are currently not completely known. However, the interplay with cells of different maturation and activation states from each niche must surely play a pivotal role in adult tissue dynamics.
MSC communication with ECs and HCs in the BM, which drives the BM niche integrity and bone tissue homeostasis and repair, is discussed in this section. The proper reproduction of these interactions in experimental approaches is mandatory for revealing fundamental properties of the regenerative process and creating rational cell-based therapeutic www.ecmjournal.org strategies. The understanding of the relationships between these cells is loaded by difficult definitions of certain cell phenotypes and functionalities, as they might share cell origin, i.e., mesenchyoangioblast and hemangioblats, where progenies possess endothelial and hematopoietic signatures (Angelos et al., 2018; Breitbach et al., 2018; Guibentif et al., 2017) . By protecting the primitive stem cells from exhaustion and, on the other side, supporting extensive progenitor activation and differentiation when needed , the spatial arrangement of the BM hubs is responsible for governing heterogeneity within cell populations (Crisan and Dzierzak, 2016) . Cell-to-cell communication includes interaction between membrane and cytoplasm and production of growth factors and cytokines. Extracellular vesicles containing proteins, lipids, miRNA, piRNA (De Luca et al., 2016) , or mitochondria transfer (MahroufYorgov et al., 2017) are important mechanisms of cell communication between MSCs and HCs (De Luca et al., 2016) , as well as ECs (Gong et al., 2017; Qin and Zhang, 2017) and cancer cells (Lin et al., 2016) , regulating their differentiation, migration, and survival. MSCs provide an instructive environment for angiogenesis, hematopoiesis, and osteopoiesis but also functional assistance to local and disseminated unhealthy or malignant cells (Dhawan et al., 2016; Lee et al., 2012; Roccaro et al., 2014; .
MSCs and ECs
Stem cell behavior, tissue formation and regeneration as well as survival of bone grafts are under the control of the blood vessels, which supply oxygen and nutrients to the cells (Böhrnsen and Schliephake, 2016; . Controlled diffusion of ROS, BM blood-vessel-forming ECs and vascular integrity determine and regulate HSPC as well as MSC localization and functionality (Fehrer et al., 2007; Gomariz et al., 2018; Langen et al., 2014; . Low permeable endosteal vessels with high integrity (H-type) differ from sinusoidal vessels with low integrity (L-type) and provide a poor ROS microenvironment, favoring HSPC maintenance, while fenestrated L-type vessels allow for HSPC respiration and mobilization . Sca-1 + and Nestin + MSCs are likewise associated with H-type vessels and sensitivity to ROS with HSPCs . During aging, reduction of H-type vessels A bidirectional synergetic cross-talk is present in the MSC niche, which is ultimately responsible for the modulation of the dynamic state of multicellular tissues -e.g., external signals can change cell DNA transcription, while, in turn, signal transduction from the interior of the cell can modify the extracellular chemistry and mechanics (Bottaro et al., 2002) . These interactions may comprise: (1) receptor recognition of insoluble and soluble ECM components -such as cytokines, growth factors, morphogenetic proteins, collagenous proteins, proteoglycans; (2) systemic factors through the vascular system; (3) paracrine and endocrine signals from local or distant sources, e.g., small-molecule agonists, steroid hormones, cytokines, peptides, ions; (4) cellcell interactions with the neighbor cells, such as niche-supporting cells, immune cells, ECs, or nerve cells; (5) environmental cues, including shear forces, pH effects, oxygen tension; (6) ECM mechanotransduction based on matrix elasticity and geometry. 92 www.ecmjournal.org AR Pereira et al. Mimicking the MSC niche in vitro results in decreased levels of SCF and PDGFRβ + or NG2 + perivascular stromal cells, which is associated with a decrease in the HSPC population in the BM . Endothelial to mesenchymal transition, an example of cell plasticity, generating pro-inflammatory ECs (Al-Soudi et al., 2017; , is often observed in adult pathologies (Erba et al., 2017; Medici and Olsen, 2012) , musculoskeletal injury (Agarwal et al., 2016) , and heterotopic bone ossification (Sun et al., 2016) , but is also recognized as a developmental process connecting maturation and fate of MSCs and ECs.
MSC-EC cross-talk leads to the modulation of the angiogenic response, with MSCs behaving as pericyte-like cells in the stabilization of newly formed blood vessels (Duttenhoefer et al., 2013; Herrmann et al., 2014; Loibl et al., 2014) . However, current data are conflicting. MSCs attenuate activation, proliferation and angiogenesis of ECs, through the production of MMP-1 and ROS, leading to EC apoptosis, capillary degeneration (Marfy-Smith and Clarkin, 2017; Otsu et al., 2009) , and, finally, disease (Cipriani et al., 2007) . In contrast, MSC-EC crosstalk stimulates proliferation and osteogenesis in MSCs and angiogenesis in ECs (Bidarra et al., 2011; Böhrnsen and Schliephake, 2016) . While BM endothelial progenitors, considered to be CD34 + or CD133 + cells, downregulate osteogenesis in MSCs , EC progenitorderived growth factors are of critical importance for MSC engraftment, stemness, and repopulation in secondary grafts and osteogenesis (Lin et al., 2014) .
MSCs and HCs
Crosstalk of MSCs and HSPCs is one of the most studied issues in physiological homeostasis and adult tissue regeneration (Chan et al., 2015; Raggatt et al., 2014) , where progenies of these cells are major participants in immune response, inflammation resolution, and tissue repair. Coherency of the skeletal system and hematopoiesis maintenance (Visnjic et al., 2004) contributes to the BM as stem cell niche environment, as described above. Many mechanisms of HSPC activation by infections or various cytokines have been revealed, while the major pathways involved in steady state and emergency hematopoiesis, generating the full repertoire of immune cells, are still not understood (Boulais and Frenette, 2015; Crisan and Dzierzak, 2016) . In case of an altered MSC contribution to osteoblast or adipocyte pool in the BM, biased hematopoiesis occurs through disbalanced myelo-/lymphopoiesis. Distinct stromal cell factors -such as SCF, CXCL12, Flt3 ligand, Wnt3a, angiopoietin-like proteins, thrombopoietin, and fibroblast growth factor 1 -control HSPC quiescence, survival, proliferation, self-renewal, and mobilization or retention in their niche (Crisan and Dzierzak, 2016; Wohrer et al., 2014) . Deletion of CXCL12 from perivascular stromal cells or osteoblasts depletes HSPCs and early lymphoid progenitors, respectively (Ding and Morrison, 2013) . Leptin receptor + perivascular stromal cells are the main source of SCF and CXCL12 in the BM (Ding and Morrison, 2013; Zhou et al., 2014) and conditional deletion of SCF leads to the depletion of quiescent HSPCs (Zhou et al., 2014) , while deletion of CXCL12 leads to HSPC mobilization (Ding and Morrison, 2013) . Since the fast onset of HSPC differentiation in culture complicates the ex vivo amplification of HSCPs for their clinical application, development of improved HSPC-amplifying strategies where HSPCs retain their stem cell capacity are still in progress. MSCs support the proliferation of ex-vivoexpanded committed hematopoietic progenitors (Hammoud et al., 2012) and their co-culture in 3D macroporous hydrogel scaffolds, mimicking the spongy architecture of trabecular bone, results in higher CD34
+ frequency (Raic et al., 2014) . However, the impact of MSCs on HSPC stemness during different in vitro cultivation and repopulating activity in SCID remains unclear. MSC effects on mature or differentiated HCs are widely studied, particularly in order to reveal the immunobiology of MSCs, where their immunosuppressive capacity is attempted to be harnessed in clinical settings (Galleu et al., 2017; Simonson et al., 2015; Trento et al., 2018) . On the contrary, functional adjustment of MSCs in hematologic malignancies, including acute lymphoblastic or myeloid leukemia, multiple myeloma, lymphomas, chronic myeloid leukemia, and myelodysplastic syndromes are described (Civini et al., 2013; de la Guardia et al., 2017) , while it is still unknown whether malignant hematopoietic progenitors modify MSCs or if leukemia-triggering changes occur first in MSCs and the healthy marrow niche (Schroeder et al., 2016) .
The murine Lin − Sca-1 + cKit + population, referred to as HSPCs, controls MSC differentiation, stimulating osteogenesis through the production of BMP-2 and -6, while, in aged and osteoporotic mice, HSPCs fail to generate BMPs (Jung et al., 2008) . Also, in vitro co-culturing demonstrates that murine HSPCs impact clonogenicity and favor an osteogenic gene expression profile in MSCs (Jung et al., 2008) . On the other hand, differentiated HCs may also affect MSC features, directly through the modulation of their properties as constitutive cells of the mutual niche or indirectly through paracrine activity and feedback effects (Vasandan et al., 2016) .
Increased megakaryocyte numbers in the BM are associated with elevated BMP-2, -4, and -6 in mice and are followed by stimulation of MSC osteogenesis (Garimella et al., 2007) . While osteoblast maturation and skeletal homeostasis might be supported by megakaryocyte (Alvarez et al., 2018; Kacena et al., 2006) , data regarding the effects on osteoclastogenesis suggest inhibitory effects of megakaryocyte on osteoclast development and functions (Beeton et al., 2006; Ciovacco et al., 2010; Kim et al., 2018) . In vitro studies show that www.ecmjournal.org monocytes can induce osteogenesis in MSCs through cell contact, which leads to the activation of STAT3 signaling followed by upregulation of Runx2, ALP, and Oncostatin M and downregulation of DKK1 in MSCs (Nicolaidou et al., 2012) . From these data, it is clear that bidirectional interactions of MSCs and HCs at different developmental stages regulate local tissue functionality and their elucidation particularly contributes to the understanding of normal as well as malignant stem cell biology.
MSCs and Mɸ
Mɸ are phagocytic myeloid cells involved in inflammatory processes through dead cell and foreign material degradation. Mɸ pool contains selfrenewable embryonic Mɸ, which are established before the emergence of adult Mɸ which derive from marrow immature myeloid progenitors or circulating monocytes (Gomez Perdiguero et al., 2015; Yona et al., 2014) . Mɸ are functionally specialized in lung, liver (Kupffer cells), or bone, where multinucleated OC near the bone surface participate in physiologic or pathologic bone resorption Park et al., 2014; Wu et al., 2015) . OC dissolve crystalline hydroxyapatite (Wenisch et al., 2003) and degrade the collagen-rich organic bone matrix (Henriksen et al., 2006) . Due to their plasticity, Mɸ may have an anti-inflammatory (M2) or pro-inflammatory (M1) profile as well as many intermediate activation states. MSCs can facilitate monocyte to macrophage transition, but attenuate (Vasandan et al., 2016) or favor their pro-inflammatory and osteoclastic activities (Gamblin et al., 2014) . MSCs induce a M2 phenotype in BM-Mɸ, increasing their expression of arginase-1, IL-10, IL-4, and CD206 and decreasing the expression of IL-6, MCP-1, and iNOS (Cho et al., 2014; Takizawa et al., 2017) . Through the production of major osteoclastogenic [e.g., RANKL (Biswas et al., 2018) and M-CSF (Cappellen et al., 2002) ] and anti-osteoclastogenic factors [e.g., OPG (Oshita et al., 2011) ], MSCs control bone resorption and remodeling (Sharaf-Eldin et al., 2016) . By producing OPG and/ or FasL protein, MSCs exert a suppressive effect on osteoclastogenesis (Shao et al., 2015; Varin et al., 2013) and are proposed to be suitable cell candidates for controlling inflammation-associated bone destruction, such as rheumatoid arthritis (Oshita et al., 2011) . However, the absence of osteoclastogenesis may be associated with reduced osteoblastic commitment of MSCs, endosteal osteoblast loss, and impaired homing (Mansour et al., 2012) or clonogenicity of HSPCs (Lymperi et al., 2011) .
MSCs and DCCs
MSC and their progeny may facilitate neoplastic growth (Doron et al., 2018) . Communication between MSCs and bone-metastatic DCCs is unclear, but it is possible that MSCs control DCC settlement in the BM as competition for niche space may exist (Dhawan et al., 2016; Gordon et al., 2014; Rossnagl et al., 2018; Shiozawa et al., 2015) . Prostate cancer cells induce an osteoblastic-type lesion, while breast cancer and myeloma cells form osteolytic-type of bone lesions (Hashimoto et al., 2018) . Human BM biopsies show higher CD271 + MSCs and CD31 + frequencies in the absence of DCCs in the BM of prostate cancer patients in comparison with breast cancer (Rossnagl et al., 2018) . SDF-1 chemokine gradient is one of the most described explanations for tumor-to-BM homing and MSC-derived osteoblasts produce SDF-1, creating a chemo-attractant gradient for CXCR4-expressing cancer cells (Amend et al., 2016; Devignes et al., 2018) . In vitro and in vivo migration assays have revealed that MSCs have tropism toward multiple myeloma cells, where MSCs promote multiple myeloma progression (Xu et al., 2012) . Although tumorhoming ability of MSCs suggests their utilization in anti-tumor strategies, it is still unknown how MSCs in the metastatic niche of the BM contribute to graft versus tumor reaction, one of the currently most investigated anti-tumor approaches. Exosomal transfer of miRNAs from MSCs to breast DCCs (Ono et al., 2014) induces MSCs dormancy in the BM niche. Moreover, multiple-myeloma-cell-derived exosome miRNA promotes a phenotype switch of MSCs towards a cancer-associated fibroblast state . Concerning tumor persistence, there is a complex bidirectional crosstalk of MSCs and cancer cells involving various mechanisms which are still unclear but important for the understanding of peculiarities of normal and stem cell niche in tumors.
ECM dynamics
Although the crucial importance of cellular interactions with surrounding elements is recognized, a major challenge is still to understand how the chemical composition and mechanical properties of the ECM can functionally influence tissue homeostasis under physiological and pathological conditions.
Particularly, a better understanding on how disruption of ECM dynamics, i.e., both biochemical signaling and physical cues, contributes to progression of complex diseases will be important towards the development of new therapeutic targets in regenerative medicine.
Biochemical interactions
Microenvironmental cues, such as cellular interactions, the paracrine environment and ECMassociated proteins, critically influence MSC behavior via biochemical pathways. This is suggested by plenty of studies demonstrating that MSCs acquire tissue-specific characteristics when co-cultured with mature cells types (Csaki et al., 2009; Deng et al., 2008; Plotnikov et al., 2008; Schneider et al., 2011; Strassburg et al., 2010) or in complex biological substrates in vitro (Bosnakovski et al., 2006; Datta et al., 2005; Hoch et al., 2016; Suzuki et al., 2010) .
The oxygen tension applied to the in vitro culture also significantly influences both MSC proliferation and differention potential in a lineage-specific matter.
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Although the published literature is quite diverse and occasionally contraditory, some studies have reported that reduced oxygen tension attenuates the MSC differentiation capacity into the osteogenic lineage (D'Ippolito et al., 2006) whilst promoting adipogenic (Fink et al., 2004) and chondrogenic differentiation (Kanichai et al., 2008; Robins et al., 2005) . This correlates with the in vivo situation where chondrocytes and adipoctes reside in more hypoxic environments. Low oxygen tension also regulates MSC paracrine activity. An induced hypoxic in vitro culture stimulates an upregulation of angiogenic genes, such as VEGF and IL-6 (Hu et al., 2008) . Furthermore, in hypoxia, large amounts of SDF-1, along with its receptor CXCR4, are expressed and secreted by MSCs, stimulating their mobilization and, thus, promoting MSC-homing toward damaged tissue Rosenkranz et al., 2010 (Yang et al., 2003) , the master transcriptional regulator of the osteoblastic differentiation. Noteworthy, the ECM-MSC dynamic is rather a bidirectional system, where the lineage commitment process of MSCs also induces a remodeling of the microenvironment's chemical and mechanical characteristics. Manduca et al. (2009) have investigated the role of MMPs in osteogenic differentiation, demonstrating that preosteoblastic cells sense the microenvironment through binding of β1 integrins to fibronectin and collagen type I in the ECM, resulting in the formation of a complex with MMP-1. This complex initiates the expression of proMMP-2, required for type-I collagen and ALP proteolysis, which is involved in mineral deposition during osteogenic differentiation. These studies emphasize the crucial role of cellmatrix interactions as highly instructive elements for stem cell biologic functions including growth, differentiation, apoptosis, and, ultimately, tissue remodeling.
The importance of the environmental mechanical properties
In the context of bone, collagen fibrils comprise binding sites for mineral deposition while still keeping the structural flexibility for a tissue that would otherwise be overly rigid. Alongside, there is evidence showing that ECM physical cues not only provide support and anchorage for the cells but strongly elicit changes in gene expression and, ultimately, affect cell fate and tissue development (Chen, 2008; Engler et al., 2006; Lutolf and Hubbell, 2005) . Biologically, osteocytes trapped within the matrix are the principal sensors of mechanical forces applied to the bone, with a crucial role in local mineral deposition regulation (Klein-Nulend et al., 2013) . Likewise, for tissue engineering approaches, MSCs are sensitive to their substrate stiffness and able to detect its nano-and micro-topography or porosity (reviewed by Sun et al., 2012a) . The transduction of these mechanical stimuli into cellular processes, otherwise known as a mechanotransduction, is accomplished through direct or indirect processes (described in detail by Sun et al., 2012a; Yim and Sheetz, 2012) . Briefly, direct mechanotransduction occurs when forces applied to integrins, which are linked to the nucleus through focal adhesion interactions with the cytoskeletal protein filaments (e.g., actin and vimentin), lead to changes in gene expression through chromatin remodeling. Indirect mechanotransduction occurs either through mechanosensitive ion channels, mainly from TRP family (Ranade et al., 2015) , or through integrinmediated signal pathways (Jalali et al., 2001; Schwartz, 2010) , which internally couple with other growth factor pathways to regulate stem cell fate. Even with all the recent discoveries on how MSC behavior can be tailored by artificial mechanic features (refer to the next section for MSC environment modelling applications), there is still a poor understanding of the underlying mechanisms of biophysically-induced stem cell differentiation and how these dynamic complex feedbacks can be manipulated towards a therapeutic application.
Modelling MSC niche complexity
The extensive presence of MSC-like progenitor cells throughout the vascularized organs raises a wide range of possible therapeutic strategies intending to accelerate the tissue regenerative capacity following injury. The up-to-date therapeutic applications, either based on the stem-properties or on the paracrine and immunomodulatory competence of these cells, are highlighted in recent reviews Park et al., 2011; Peired et al., 2016; Yousefi et al., 2016) . Nevertheless, in most cases, MSC-based clinical trials occur in an early phase (phase I or II) according to FDA guidelines, where the long-term safety and treatment efficacy is not yet conclusively established (Squillaro et al., 2016 Table 1 ). Furthermore, the current limitations are highlighted and potential opportunities to fill the bridge between fundamental science and clinical application discussed.
Monolayer culture: an in vitro mechanistic tool
Culture of an adherent cell monolayer on flat and rigid 2D substrates is a well-established straightforward technique by which cells of interest can be maintained outside the body and observed over time with a good viability of cells in culture.
Paracrine factors
To date, the simplest models for examining biological behavior of MSCs in response to microenvironmental factors are conduced by direct exposition to soluble factors (Celil and Campbell, 2005; Indrawattana et al., 2004; Kratchmarova et al., 2005; Luo et al., 2010) and conditioned media from either other cell type cultures (Chowdhury et al., 2015; Menon et al., 2007; Siciliano et al., 2015) or from tissue extracts (Chen et al., 2002) . In the strictest sense, the conditioned medium refers to the cell secretome, which encompasses proteins shed from the cell surface and intracellular proteins released through non-classical secretion pathway or exosomes, including numerous enzymes, growth factors, cytokines and hormones, or other soluble mediators (Veronesi et al., 2017) . Therefore, conditioned medium approaches offer the possibility of studying the paracrine interactions of complex combinations of factors, in a specific physiological or pathological environment.
Co-cultures
Co-culture techniques find countless applications in biology for studying interactions between cell populations. Overall, the co-culture systems can be set-up either by direct co-culture of both cell types or using compartmented systems, such as trans-wells or microfluidic chambers, to study solely the paracrine crosstalk and not the cell-cell signaling pathways that may occur. Many studies have explored this approach by co-culturing MSCs with mature cells in direct (Aguirre et al., 2010; Ball et al., 2004; Csaki et al., 2009; Deng et al., 2008; Strassburg et al., 2010; Takigawa et al., 2017; Wang et al., 2007) and indirect contact (Li et al., 2011; Luo et al., 2009; Wei et al., 2010) . When comparing cultures of MSCs and osteoblasts alone with MSC/osteoblast co-cultures, for example, an increase in calcification over time is observed in co-culture. These results suggest the idea of a positive augmentation of the MSC differentiation process by osteoblast-secreted factors (Glueck et al., 2015) .
Protein-coating
The native ECM is essentially a 3D network of fibrillar and non-fibrillar proteins, such as collagens, fibronectin, elastin, laminin, vitronectin, glycosaminoglycans, such as hyaluronan or heparin, and proteoglycans (Bason et al., 2018) . Many of these ECM components are commercially available, either as complex mixtures (e.g., matrigel) or as purified proteins and are extensively applied to guide MSC differentiation in vitro (Curran et al., 2006; Phillips et al., 2010; Qian and Saltzman, 2004; Rojo et al., 2016) . To achieve a high chemical complexity, MSCs are also cultured on decellularized extracellular 2D coatings, i.e., matrix produced by cells in vitro, resulting in a composition of cell-secreted components without the potentially antigenic cellular structures or contaminating DNA after collection and processing (Hoshiba et al., 2010) . The enhancement of proliferation and stemness maintenance of naïve MSCs is verified in cells cultured on a basal-cultured MSC-derived decellularized ECM; while, when cultured on decellularized ECM deposited by MSCs under osteogenic differentiation, an osteogenic lineage differentiation is observed in seeded MSCs cultured in the absence of dexamethasone (Rao et al., 2014) .
Limitations
Although very convenient and effective for mechanistic purposes, the results from 2D cell culture models may not be representative of essential and complex features of native microenvironments. A main limitation of in vitro studies in 2D monolayer cultures is the lack of spatial and temporal control of multiple signals, similar to what happens in a native 3D context. Furthermore, a significant limitation of 2D cell cultures is that diffusion and transport conditions do not reflect the in vivo situation -cells grown in monolayers are exposed to a uniform environment with constant supply of oxygen, nutrients or metabolic products, which can lead to significant deviations in cellular function and response (Baker et al., 2012) .
Paradigm shift: mimicking MSC niche environment through third dimension
Due to the lack of structural architecture, 2D cell culture models are substantially diverging from the in vivo state (Fig. 2) . Accordingly, many research groups apply a 3D culture environment that aims to better resemble the native tissue organization.
Spheroids culture
Since the observation that chondrocytes lose their phenotype quickly in monolayer culture (Caron et al., 2012; Thompson et al., 2017) , micromasses and pellet in vitro cultures have been established, allowing cells to aggregate in high densities and create their own 3D cartilaginous matrix (Cottrill et al., 1987; Johnstone et al., 1998) . In addition, using a simple 3D scaffold-free spheroid culture system, Wang et al. (2009) have demonstrated that MSC multipotency can be significantly increased for both osteogenic and adipogenic lineage when compared with the conventional 2D monolayer culture. Moreover, using a perivascular-like in vitro 3D spheroid coculture system, Saleh et al. (2011) have shown that endothelial cells regulate MSC activity by maintaining quiescence and facilitating niche exit by osteogenic differentiation through activation of endogenous Wnt and BMP signaling. Other studies have reported enhanced anti-inflammatory properties after a short period of spheroid culture by increased expression of genes, such as CXCR4, which promotes adhesion, or IL-24, with tumor-suppressing properties (Bartosh et al., 2010; Potapova et al., 2008; Ylöstalo et al., 2012) .
Micropatterning
A different approach being adopted is the creation of a pseudo-3D environment for MSCs using soft lithography techniques to imprint a topographypatterning in the culture substrates. This is rather a bottom-up organization approach, with cells being instructed at the molecular level. Several studies have shown increased mineralization during osteogenesis induction on micro-and/or nano-patterning growth surfaces (McNamara et al., 2010; Oh et al., 2009; Yim et al., 2007; Zhao et al., 2012) . Differences in groove size as well as their geometric arrangement dictate the matrix alignment and cell morphology, resulting in a strong effect on cell proliferation and gene expression and eventually induction of bone nodules formation. Dalby et al. (2007) have shown that MSC osteogenic differentiation can be initiated with a nanopitted topographical pattern in a square geometry with a moderate level of disorder embossed into PMMA surfaces; while, on the other hand, an ordered square nanopit-pattern is proposed to mediate retention of MSC stemness (McMurray, 2011) . Also, Stanciuc et al. (2018) have shown an accelerated maturation of human osteoblast maturation on micro-rough surfaces of zirconia-toughened alumina with nanoporosity obtained by selective chemical etching. et al. (2006) have demonstrated for the first time that the substrate stiffness itself can direct MSC lineage fate. Subsequently, Pek et al. (2010) have optimized a 3D hydrogel system to guide MSC differentiation either to neural, myogenic, or osteogenic phenotypes depending on whether they are cultured in gels of elastic moduli in the lower (7 Pa), intermediate (25 Pa), or higher range (75 Pa), respectively. Interestingly, the matrix that optimally drives MSC differentiation to specific lineages corresponds to the stiffness of the relevant target tissue. Accordingly, tuning the elasticity of the culture material is a common strategy, adopted to control MSC fate Huebsch et al., 2015; Kuboki and Kidoaki, 2016; Seib et al., 2009; Wingate et al., 2012) .
Substrate stiffness
Engler
The influence of the chemical and physical biomaterial properties
Progress in the development of biomimetic materials have lately been chasing the complexity of the mechanical and physical-chemistry arrangement of the biomaterial itself, such as a scaffold, commonly used for tissue engineering applications. Such tissueengineered constructs not only represent potential therapeutic options for the treatment of bone defects but may also serve as a model system of the MSC naïve environment in the bone and facilitate our understanding of the interactions within the niche.
3D gel matrices/scaffolds
For tissue engineering applications, the culture substrate should not only provide physical support but also present a functional surface chemistry compliant with the biological purpose. Noteworthy, the chemical composition as well as the fabrication process itself determine the final geometry, porosity, and roughness of the bulk material (Akbarzadeh and Yousefi, 2014; Loh and Choong, 2013; Pina et al., 2016) . The macroporosity (pores > 50 μm) of a scaffold 98 www.ecmjournal.org
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contributes to osteogenesis by facilitating cell and ion transport (Bignon et al., 2003) , while microporosity (pores < 20 μm) augments bone growth by providing attachment points for osteoblasts (Bignon et al., 2003) and increasing growth factors retention upon which bone formation depends in ectopic sites (Hing et al., 2005; Woodard et al., 2007) . Commonly used natural polymers for bone tissue engineering are collagen, fibrin, alginate, silk, hyaluronic acid, and chitosan. They provide high biological recognition that may positively support cell adhesion and function, yet often lack the mechanical strength required by bone (reviewed by O'brien, 2011). Synthetic biodegradable polymers, such as PLA, PGA, and PCL are widely used due to their reproducible large-scale production, with controlled properties of strength, degradation rate, and microstructure (reviewed by O'brien, 2011). Calciumphosphate-based materials, such as hydroxyapatite and beta-tricalcium phosphate, are widely used ceramics that often shape the inorganic-phase of bone graft substitutes. Their non-toxic, non-inflammatory, non-immunogenic properties and their biological affinity (i.e., ability to form direct chemical bonds with the surrounding environment) direct tissue integration when implanted in bone defects (Ambard and Mueninghoff, 2006; Venkatesan and Kim, 2014) . Besides, extensive studies of organic modifications of hydroxyapatite-based composites show the enhancement of the osteoconductive properties of the material (review by Swetha et al., 2010) . For example, Zhao et al. (2006) have investigated two types of biomimetic composite materials, chitosan-gelatin and hydroxyapatite/chitosan-gelatin. They have shown that hydroxyapatite enhances protein and calcium ion adsorption -which in turn improves i) initial celladhesion and long-term growth, ii) maintains MSC stemness and iii) upon induction enhances osteogenic differentiation (Zhao et al., 2006) .
Engineered substrates
The tissue engineering field provides valuable knowledge for modeling the MSC niche in vitro. Moreover, advances in protein engineering and synthetic chemistry of peptide-conjugated polymers allow the fabrication of the so-called artificial ECM constructs, which can respond to cell-secreted signals and enable proteolytic matrix remodeling (Lutolf and Hubbell, 2005) . These synthetic networks are typically achieved by crosslinking of specific bioactive components in a structural mesh -e.g., (1) cell-adhesive ligands, such as integrin-binding peptides of the prototypical RGD family, resulting in an increased cell growth efficiency (Chang et al., 2009; Maia et al., 2014) ; (2) domains with susceptibility to degradation by cell-secreted proteases to facilitate bidirectional cell-matrix interactions (Lutolf et al., 2003) ; (3) binding sites for growth factor matching the pretended application (Madl et al., 2014; Park et al., 2009) . Thevenot et al. (2010) have developed a PLGA scaffold with incorporated SDF-1 to enhance the recruitment of endogenous MSCs to the injury site. Likewise, Phillippi et al. (2008) have created spatially defined patterns of immobilized BMP-2 using inkjet bioprinting technology to modulate the cell organization and, consequently, their differentiation toward the osteogenic lineage.
As another powerful element, synthetic biology has recently been applied to tissue engineering modeling. Encapsulated modified cells with sophisticated tunable modular genetic switches that couple repressor proteins with an RNAi can be controlled by an external factor or specific microenvironment changes (Saxena et al., 2016; Weber and Fussenegger, 2012) .
3D biofabrication
Combined knowledge of material science and 3D fabrication principles results in the advent of additive manufacturing techniques as a complex innovative approach to generate complex 3D environments with a designed and controlled arrangement of tissue morphology features and spatial distribution of cells (Bose et al., 2013; Malda et al., 2013) . 3D biofabrication is becoming popular due to the ability to directly print porous scaffolds with designed shape, controlled chemistry, and interconnected porosity. Apart from inorganic scaffold manufacturing, additive manufacturing approaches are also used to explore the possibilities in fabricating scaffolds with live cells and tissues. Levato et al. (2014) have shown a combined method where MSC-laden polylactic acid microcarriers are printed by encapsulation in gelatin methacrylamide-gellan. This combined bioprinting approach allows for the improvement of the elastic modulus of the hydrogel construct, facilitating cell adhesion and survival, while supporting osteogenic differentiation and bone matrix deposition (Levato et al., 2014) . Alternatively, Gurkan et al. (2014) have used another interesting approach where MSCs are encapsulated in a gelatin-based metacrylated hydrogel with addiction of BMP-2 and TGF-β1 mimicking the fibrocartilage phase of the bone. Incorporating bioprinting technology with a nanoliter gel droplet system, this model can induce the upregulation of osteogenesis and chondrogenesis, thus making this approach a functional tissue model system (Gurkan et al., 2014) .
Decellularized tissue
Although a variety of different materials and composites are available, to achieve a physiologically relevant protein and structural complexity, whole organ or tissue decellularization techniques are investigated. These natural scaffolds preserve the complex biochemical and biomechanical ultrastructure of the native tissue and can be recellularized to generate a new functional tissue or organ (Crapo et al., 2011; Lund et al., 2017) . Particularly, decellularized bone is used as a scaffold for bone www.ecmjournal.org tissue engineering or bone in vitro modelling due to its 3D porous structure and its natural biochemical component arrangement, providing osteoinductive properties that are not fully resembled by synthetic polymers or hydrogels (Nyberg et al., 2017) . However, the current challenge of working with decellularized matrices and their translation to clinics is to balance the decellularization methods in order to maintain the specific epitopes that will have a positive impact on cell functions but eliminate any component that could cause an immunogenic response (Gilpin and Yang, 2017; Keane et al., 2016) .
The dynamic dimension
Biomechanical stimuli caused by physical deformation and fluid shear stress generated by interstitial fluid movement through bone lacunae are recognized as a significant part of in vivo bone remodeling (Carter, 1984; Duncan and Turner, 1995) . Therefore, to better reassemble the in vivo counterpart, in vitro models for skeletal progenitors may likewise be integrated in an intrinsic dynamic environment.
Dynamic bioreactors
Dynamic culture of MSCs has expanded greatly in the last 15 years and dynamic optimized bioreactors are now widely used to provide the technological means to achieve both improved nutrient transportation and mechanical stimulation. A variety of dynamic 3D bioreactor concepts mimicking the native microenvironment of bone tissues have been developed -e.g., perfusion chambers (Dahlin et al., 2012; Hosseinkhani et al., 2006; Kleinhans et al., 2015; Porter et al., 2005; Yeatts and Fisher, 2010) , stirred tanks (Eibes et al., 2010; King and Miller, 2007) , rotating wall vessels (Nishi et al., 2013; , mechanical loading chambers (Altman et al., 2002; Baker et al., 2011; Pelaez et al., 2012; Sittichockechaiwut et al., 2009) , and, more recently, nanovibrational reactors (Tsimbouri et al., 2017) . MSCs cultured under those dynamic cultures are subjected to mechanical shear created by fluid flow, which promotes osteogenesis via the ERK1/2 pathway through upregulation of Runx2 (Yeatts et al., 2013) and, therefore, provides the right microenvironmental setup to augment bone formation (David et al., 2007; McCoy and O'Brien, 2010; Stiehler et al., 2009) .
Microfluidic chips
The advances in microfluidic technology brought great progresses in the field of dynamic in vitro models, mainly regarding the spatiotemporal control of gradients and the introduction of individual or combination of factors with low volumes and low cell suspension density requirements (Sart et al., 2016; Sun et al., 2012b; Tatárová et al., 2016) . Recently, Marturano-Kruik et al. (2018) have developed a perivascular model containing ECs and MSCs seeded on a bone matrix, forming a bone perivascular nicheon-a-chip, which allows following slow-cycling metastatic cancer cells in a BM niche.
Smart materials
Meanwhile, advances in the material science field have been made with the development of the socalled 'smart' materials -i.e., biomaterials specifically designed to allow dynamic changes in their structure in response to an external stimulus (Kaliva et al., 2017) . These materials can be metals or polymers sensitive either to temperature (Dessì et al., 2013; Roy et al., 2013) , pH , magnetic (Ribeiro et al., 2016) or electrical fields (Balint et al., 2014) , light (Muraoka et al., 2009; Zhao, 2012) , or lytic-enzymes (Hu et al., 2012; Todd et al., 2007) . The concept of a dynamic 4 th dimension is also being explored in 3D printing approaches for tissue engineering (reviewed by Gladman et al. , 2016; Khoo et al., 2015) . The development of new tailored inks capable of adapting their shape or functionalities to external stimuli will surely be a pivotal milestone in achieving reliable and close to in vivo MSC niche models.
In vivo models
Animal models are a vital part of MSC biology research and MSC-based therapeutic approaches, enabling investigations at the systemic level in a physiological environment. Nevertheless, the prediction of effectiveness of a therapeutic approach in preclinical models can be highly inaccurate, resulting in hurdles upon translation of results in clinics. This frequent discrepancy happens mainly due to (1) intrinsic divergence of molecular mechanisms between species and the non-human stromal component of the ECM, or (2) anatomic discrepancies particularly in orthopedic applications. These facts, along with high costs of maintenance, need for qualified expertise, limited output analysis, and ethical concerns about animal experimentation are motivating governments and regulatory organizations to limit their use and support the implementation of alternative methods following the 3R's principles -firstly established by Russell in 1959 (Russell et al., 1959 ). Yet, improvements in modeling the complex bone environment (as discussed in the present review) present promising options to provide tissue grafts for regenerative medicine in large bone fractures and, also, to screen with precision therapeutic agents that may facilitate bone repair.
Final remarks
In vitro models should not be confined to single stationary conditions; i.e., an individual architecture or a particular chemical functionalization with a specific biological function. Instead, it is desirable that the emerging constructs should comprise complex combinatorial signals with tunable cues, to support stemness maintenance or direct stem cell differentiation with spatiotemporal control. Nevertheless, successes in various aspects of the tissue engineering assure a bright future for the development of models that mimic the relevant properties of naïve tissues. The progressive increase in complexity of in vitro models that is been 100 www.ecmjournal.org AR Pereira et al. Mimicking the MSC niche in vitro witnessed is surely paving the way towards a better understanding of the detailed biological events involved in tissue homeostasis and related disorders in vivo.
Further perspectives
The localization, identification, and regenerative potential of MSCs is under controversial discussion in the stem cell community. This is mainly attributed to the lack of distinct surface markers for the identification and prospective isolation of naïve MSC/ tissue-specific progenitor cells in vivo in mouse and human, resulting in inconsistences of the studied cell population, and the restriction of many studies to the assessment of the cell regenerative potential in vitro. The in vitro MSC characterization methods are highly artificial and do not proof the function of MSC/tissue-specific progenitor cells in vivo. Indeed, there is an ambiguous distinction between the physiological function of isolated MSCs in culture and their presumed in vivo counterpart -i.e., MSCs isolated from the BM give rise to all the mesenchymal cell lineages (Pittenger et al., 1999) and even transdifferentiate into cells from the central nervous system (Wislet-Gendebien et al., 2005) , the skeletal muscle system (Ferrari et al., 1998) , the hepatic system (Lee et al., 2004) , and the cardiac system (Toma et al., 2002) when exogenously stimulated; whereas naïve non-stimulated BM-MSCs do not share the same phenotypic plasticity (Bara et al., 2014) . In fact, robust in vivo assays of progenitor cells from other tissues, all sharing the in vitro characteristics attributed to MSCs (Dominici et al., 2006) , suggest that distinct tissue-specific stem/progenitor cells with distinct regenerative capacity exist throughout the body (Robey, 2017; Sipp et al., 2018) , specifically settled in a specific environment which control either the maintenance of their stemness or the orchestration of tissue modulation activities. This, along with the increasing amount of data showing a microenvironmental-dependent behavior of MSCs, as reviewed in the present article, highlights the importance of considering and implementing microenvironmental cues upon assessment of the MSC regenerative potential. Although substantial advances have already been made in the field, the recapitulation of the complex biological recognition and signaling functions, e.g., between cells and ECM, is still crucial and controlling the dynamics and spatial organization of multiple signals remains a current challenge. Substantial testing and optimization is still required to ensure that the 3D constructs realistically mimic the native tissue counterparts. Accordingly, despite the unquestionable value of MSCs for clinical applications, comprehensive studies of fundamental mechanisms triggered by microenvironmental cues are critical before moving to regenerative medicine cell therapy applications.
The future holds great potential for 3D/4D models for studying tissue dynamics in health and disease as well as for tissue engineering applications. Progress in engineering, technology, biomaterials, and imaging will surely be at the forefront of the MSC niche model revolution. www.ecmjournal.org www.ecmjournal.org AR Pereira et al. Mimicking the MSC niche in vitro can be assumed that both tissue-specific as well as common mechanisms control MSC fate in distinct niches. However, future research will be required to unravel these mechanisms, which will be also critical to resemble specific niche features in in vitro models. Blanc et al., 2008; Ringdén et al., 2006 ; additional references), indicating therapeutic value of these cells independent of the fact that they might be an in vitro artefact.
